Exact Mass: 434.2069

Exact Mass Matches: 434.2069

Found 286 metabolites which its exact mass value is equals to given mass value 434.2069, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dexamethasone Acetate

Dexamethasone-17-acetate

C24H31FO6 (434.2105)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; EAWAG_UCHEM_ID 3264 CONFIDENCE standard compound; INTERNAL_ID 2835

   

Extracort

Triamcinolone acetonide

C24H31FO6 (434.2105)


CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8728; ORIGINAL_PRECURSOR_SCAN_NO 8723 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8791; ORIGINAL_PRECURSOR_SCAN_NO 8789 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8741; ORIGINAL_PRECURSOR_SCAN_NO 8739 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8700; ORIGINAL_PRECURSOR_SCAN_NO 8699 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8788; ORIGINAL_PRECURSOR_SCAN_NO 8786 CONFIDENCE standard compound; INTERNAL_ID 637; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8777; ORIGINAL_PRECURSOR_SCAN_NO 8775 D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents CONFIDENCE standard compound; INTERNAL_ID 2826 D000893 - Anti-Inflammatory Agents

   

Flunisolide

(1S,2S,4R,8S,9S,11S,12S,13R,19S)-19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icosa-14,17-dien-16-one

C24H31FO6 (434.2105)


Flunisolide is only found in individuals that have used or taken this drug. It is a corticosteroid often prescribed as treatment for allergic rhinitis.Flunisolide is a glucocorticoid receptor agonist. The antiinflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding. Flunisolide binds to plasma transcortin, and it becomes active when it is not bound to transcortin. R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents CONFIDENCE standard compound; INTERNAL_ID 2812 D000893 - Anti-Inflammatory Agents

   

Paramethasone Acetate

6alpha-fluoro-11beta,17alpha,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione acetate

C24H31FO6 (434.2105)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid Same as: D01229

   

9alpha-Fluoro-6alpha-methylprednisolone 21-acetate

9alpha-Fluoro-6alpha-methylprednisolone 21-acetate

C24H31FO6 (434.2105)


   

4,5-Dihydro-drospirenone-3-sulfate

(2S,4R,10S,14S,16S,18S)-10,14-dimethyl-5-oxospiro[hexacyclo[9.8.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁹.0¹⁶,¹⁸]nonadecane-15,2-oxolane]-7-sulfonic acid

C24H34O5S (434.2127)


4,5-Dihydro-drospirenone-3-sulfate is a metabolite of drospirenone. Drospirenone, also known as 1,2-dihydrospirorenone, is synthetic, steroidal progestin with additional antimineralocorticoid and weak antiandrogen properties which is used as a hormonal contraceptive. It is sold under the brand names Yasmin, Yasminelle, Yaz, Beyaz, Ocella, and Angeliq, all of which are combination products of drospirenone with an estrogen such as ethinylestradiol. (Wikipedia)

   

Dexamethasone acetate

2-{1-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetate

C24H31FO6 (434.2105)


   

p-MPPF

4-fluoro-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}-N-(pyridin-2-yl)benzamide

C25H27FN4O2 (434.2118)


   

Kenalog

12-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one

C24H31FO6 (434.2105)


   

Nasalide

19-fluoro-11-hydroxy-8-(2-hydroxyacetyl)-6,6,9,13-tetramethyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one

C24H31FO6 (434.2105)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents

   

Paramethasone acetate

2-{8-fluoro-14,17-dihydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl}-2-oxoethyl acetate

C24H31FO6 (434.2105)


   

(E)-7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-3-(4-hydroxyphenethyl) isocoumarin|Achlisocoumarin I

(E)-7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-3-(4-hydroxyphenethyl) isocoumarin|Achlisocoumarin I

C27H30O5 (434.2093)


   

himeic acid C

himeic acid C

C22H30N2O7 (434.2053)


   

sacranoside B

sacranoside B

C20H34O10 (434.2152)


   

beilschmiedic acid N

beilschmiedic acid N

C27H30O5 (434.2093)


   

rel-(7R,8R,7S,8R)-3,4,4-trihydroxy-3-[1-methyl-2-(4-hydroxyphenyl)]ethyl-7,7-epoxylignan|ribesin G

rel-(7R,8R,7S,8R)-3,4,4-trihydroxy-3-[1-methyl-2-(4-hydroxyphenyl)]ethyl-7,7-epoxylignan|ribesin G

C27H30O5 (434.2093)


   

parviflorone C

parviflorone C

C27H30O5 (434.2093)


   

8-(3,4-Dihydro-5-methoxy-6,8,8-trimethyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-3-yl)-2,2-dimethyl-2H-1-benzopyran-5-ol

8-(3,4-Dihydro-5-methoxy-6,8,8-trimethyl-2H,8H-benzo[1,2-b:3,4-b]dipyran-3-yl)-2,2-dimethyl-2H-1-benzopyran-5-ol

C27H30O5 (434.2093)


   

parviflorone D

parviflorone D

C27H30O5 (434.2093)


   

(2R,3R,4R,5S,6S)-3,4,5-Tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-ol

(2R,3R,4R,5S,6S)-3,4,5-Tris(benzyloxy)-6-methyltetrahydro-2H-pyran-2-ol

C27H30O5 (434.2093)


   

(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran<2,3:7,8>flavanone

(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran<2,3:7,8>flavanone

C27H30O5 (434.2093)


   

SCHEMBL11228707

SCHEMBL11228707

C21H30N4O4S (434.1988)


   

Trp Met Val

Trp Met Val

C21H30N4O4S (434.1988)


   

Trp Val Met

Trp Val Met

C21H30N4O4S (434.1988)


   

Cys Leu Trp

Cys Leu Trp

C21H30N4O4S (434.1988)


   

Cys Trp Leu

Cys Trp Leu

C21H30N4O4S (434.1988)


   

Val Trp Met

Val Trp Met

C21H30N4O4S (434.1988)


   

Met Trp Val

Met Trp Val

C21H30N4O4S (434.1988)


   

Trp Cys Leu

Trp Cys Leu

C21H30N4O4S (434.1988)


   

Betamethasone Acetate

Betamethasone 21-Acetate

C24H31FO6 (434.2105)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2032 CONFIDENCE standard compound; EAWAG_UCHEM_ID 3244

   

76-25-5

76-25-5

C24H31FO6 (434.2105)


   

MLS002153928-01!FluniSOLIDe3385-03-3

MLS002153928-01!FluniSOLIDe3385-03-3

C24H31FO6 (434.2105)


   

MLS001148106-01!DEXAMETHASONE 21-ACETATE

MLS001148106-01!DEXAMETHASONE 21-ACETATE

C24H31FO6 (434.2105)


   

MLS001148264-01!76-25-5

MLS001148264-01!76-25-5

C24H31FO6 (434.2105)


   

MLS001332652-01!Flunisolide3385-03-3

MLS001332652-01!Flunisolide3385-03-3

C24H31FO6 (434.2105)


   

Triamcinolone acetonide

Triamcinolone acetonide

C24H31FO6 (434.2105)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents

   

Ala Ala His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H26N8O5 (434.2026)


   

Ala Phe Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H30N4O6 (434.2165)


   

Ala Phe Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Ala His Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H26N8O5 (434.2026)


   

Ala His His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H26N8O5 (434.2026)


   

Ala Pro Phe Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-3-hydroxybutanoic acid

C21H30N4O6 (434.2165)


   

Ala Pro Thr Phe

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-aminopropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Ala Thr Phe Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Ala Thr Pro Phe

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-aminopropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Asp Ile Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Asp Ile Thr Ser

(3S)-3-amino-3-{[(1S,2S)-1-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Asp Leu Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Asp Leu Thr Ser

(3S)-3-amino-3-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Asp Ser Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Asp Ser Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Asp Ser Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Asp Ser Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Ile Ser

(3S)-3-amino-3-{[(1S,2R)-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Leu Ser

(3S)-3-amino-3-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Ser Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Ser Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Thr Val

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C17H30N4O9 (434.2013)


   

Asp Thr Val Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-carboxypropanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Asp Val Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Glu Ile Ser Ser

(4S)-4-amino-4-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Leu Ser Ser

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Ile Ser

(4S)-4-amino-4-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Leu Ser

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Thr Val

(4S)-4-amino-4-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Ser Val Thr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Thr Ser Val

(4S)-4-amino-4-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Thr Val Ser

(4S)-4-amino-4-{[(1S,2R)-1-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Val Ser Thr

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Glu Val Thr Ser

(4S)-4-amino-4-{[(1S)-1-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Phe Ala Pro Thr

(2S,3R)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanoic acid

C21H30N4O6 (434.2165)


   

Phe Ala Thr Pro

(2S)-1-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]propanamido]-3-hydroxybutanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Phe Pro Ala Thr

(2S,3R)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-hydroxybutanoic acid

C21H30N4O6 (434.2165)


   

Phe Pro Thr Ala

(2S)-2-[(2S,3R)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxybutanamido]propanoic acid

C21H30N4O6 (434.2165)


   

Phe Thr Ala Pro

(2S)-1-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxybutanamido]propanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Phe Thr Pro Ala

(2S)-2-{[(2S)-1-[(2S,3R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C21H30N4O6 (434.2165)


   

Gly Pro Val Tyr

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C21H30N4O6 (434.2165)


   

Gly Pro Tyr Val

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Gly Val Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C21H30N4O6 (434.2165)


   

Gly Val Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Gly Tyr Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Gly Tyr Val Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

His Ala Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H26N8O5 (434.2026)


   

His Ala His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H26N8O5 (434.2026)


   

His His Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]propanoic acid

C18H26N8O5 (434.2026)


   

Ile Asp Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ile Asp Thr Ser

(3S)-3-[(2S,3S)-2-amino-3-methylpentanamido]-3-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Ile Glu Ser Ser

(4S)-4-[(2S,3S)-2-amino-3-methylpentanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Val Met Trp

Val Met Trp

C21H30N4O4S1 (434.1988)


   

Ile Ser Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ile Ser Glu Ser

(4S)-4-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ile Ser Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ile Ser Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Ile Thr Asp Ser

(3S)-3-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Ile Thr Ser Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Lys Asn Ser Ser

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Lys Ser Asn Ser

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Lys Ser Ser Asn

(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]propanoic acid

C16H30N6O8 (434.2125)


   

Met Trp Val

Met Trp Val

C21H30N4O4S1 (434.1988)


   

Leu Asp Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Leu Asp Thr Ser

(3S)-3-[(2S)-2-amino-4-methylpentanamido]-3-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Leu Glu Ser Ser

(4S)-4-[(2S)-2-amino-4-methylpentanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Leu Ser Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Leu Ser Glu Ser

(4S)-4-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Leu Ser Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Leu Ser Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Leu Thr Asp Ser

(3S)-3-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Leu Thr Ser Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Met Val Trp

Met Val Trp

C21H30N4O4S1 (434.1988)


   

Asn Lys Ser Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-3-hydroxypropanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Asn Ser Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]hexanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Asn Ser Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-hydroxypropanamido]hexanoic acid

C16H30N6O8 (434.2125)


   

Pro Ala Phe Thr

(2S,3R)-3-hydroxy-2-[(2S)-3-phenyl-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C21H30N4O6 (434.2165)


   

Pro Ala Thr Phe

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Pro Phe Ala Thr

(2S,3R)-3-hydroxy-2-[(2S)-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C21H30N4O6 (434.2165)


   

Pro Phe Thr Ala

(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]propanoic acid

C21H30N4O6 (434.2165)


   

Pro Gly Val Tyr

(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-methyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}butanamido]propanoic acid

C21H30N4O6 (434.2165)


   

Pro Gly Tyr Val

(2S)-2-[(2S)-3-(4-hydroxyphenyl)-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Pro Thr Ala Phe

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Pro Thr Phe Ala

(2S)-2-[(2S)-2-[(2S,3R)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-phenylpropanamido]propanoic acid

C21H30N4O6 (434.2165)


   

Pro Val Gly Tyr

(2S)-3-(4-hydroxyphenyl)-2-{2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]acetamido}propanoic acid

C21H30N4O6 (434.2165)


   

Pro Val Tyr Gly

2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]acetic acid

C21H30N4O6 (434.2165)


   

Pro Tyr Gly Val

(2S)-2-{2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Pro Tyr Val Gly

2-[(2S)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]acetic acid

C21H30N4O6 (434.2165)


   

Val Trp Met

Val Trp Met

C21H30N4O4S1 (434.1988)


   

Trp Val Met

Trp Val Met

C21H30N4O4S1 (434.1988)


   

Trp Met Val

Trp Met Val

C21H30N4O4S1 (434.1988)


   

Ser Asp Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ser Asp Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ser Asp Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Asp Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carboxypropanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Ile Ser

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-4-{[(1S,2S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Leu Ser

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-carboxybutanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Thr Val

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-4-{[(1S,2R)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Glu Val Thr

(4S)-4-[(2S)-2-amino-3-hydroxypropanamido]-4-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Ile Asp Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ser Ile Glu Ser

(4S)-4-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Ile Ser Glu

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ser Ile Thr Asp

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Ser Lys Asn Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Ser Lys Ser Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C16H30N6O8 (434.2125)


   

Ser Leu Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Ser Leu Glu Ser

(4S)-4-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Leu Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ser Leu Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Ser Asn Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]hexanamido]-3-hydroxypropanoic acid

C16H30N6O8 (434.2125)


   

Ser Asn Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-hydroxypropanamido]hexanoic acid

C16H30N6O8 (434.2125)


   

Ser Ser Glu Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carboxybutanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Ser Glu Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-carboxybutanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Ser Ile Glu

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-methylpentanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ser Ser Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]hexanamido]-3-carbamoylpropanoic acid

C16H30N6O8 (434.2125)


   

Ser Ser Leu Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-4-methylpentanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ser Ser Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxypropanamido]-3-carbamoylpropanamido]hexanoic acid

C16H30N6O8 (434.2125)


   

Ser Thr Asp Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Thr Asp Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Ser Thr Glu Val

(4S)-4-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Thr Ile Asp

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Ser Thr Leu Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Ser Thr Val Glu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylbutanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Ser Val Glu Thr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Ser Val Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylbutanamido]-3-hydroxybutanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Thr Ala Phe Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Thr Ala Pro Phe

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]propanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Thr Asp Ile Ser

(3S)-3-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-{[(1S,2S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Thr Asp Leu Ser

(3S)-3-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Thr Asp Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Thr Asp Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Thr Asp Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C17H30N4O9 (434.2013)


   

Thr Asp Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-carboxypropanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Thr Glu Ser Val

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Thr Glu Val Ser

(4S)-4-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Thr Phe Ala Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-phenylpropanamido]propanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Thr Phe Pro Ala

(2S)-2-{[(2S)-1-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}propanoic acid

C21H30N4O6 (434.2165)


   

Thr Ile Asp Ser

(3S)-3-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Thr Ile Ser Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxypropanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Thr Leu Asp Ser

(3S)-3-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}propanoic acid

C17H30N4O9 (434.2013)


   

Thr Leu Ser Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxypropanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Thr Pro Ala Phe

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}propanamido]-3-phenylpropanoic acid

C21H30N4O6 (434.2165)


   

Thr Pro Phe Ala

(2S)-2-[(2S)-2-{[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]propanoic acid

C21H30N4O6 (434.2165)


   

Thr Ser Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Thr Ser Asp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C17H30N4O9 (434.2013)


   

Thr Ser Glu Val

(4S)-4-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Thr Ser Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Thr Ser Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Thr Ser Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylbutanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Thr Thr Asp Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-carboxypropanamido]-3-methylbutanoic acid

C17H30N4O9 (434.2013)


   

Thr Thr Val Asp

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Thr Val Asp Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Thr Val Glu Ser

(4S)-4-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Thr Val Ser Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Thr Val Thr Asp

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Val Asp Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-carboxypropanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Val Glu Ser Thr

(4S)-4-[(2S)-2-amino-3-methylbutanamido]-4-{[(1S)-1-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Val Glu Thr Ser

(4S)-4-[(2S)-2-amino-3-methylbutanamido]-4-{[(1S,2R)-1-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Val Gly Pro Tyr

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-methylbutanamido]acetyl}pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C21H30N4O6 (434.2165)


   

Val Gly Tyr Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-methylbutanamido]acetamido}-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Val Pro Gly Tyr

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-(4-hydroxyphenyl)propanoic acid

C21H30N4O6 (434.2165)


   

Val Pro Tyr Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]acetic acid

C21H30N4O6 (434.2165)


   

Val Ser Glu Thr

(4S)-4-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-4-{[(1S,2R)-1-carboxy-2-hydroxypropyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Val Ser Thr Glu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Val Thr Asp Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-carboxypropanamido]-3-hydroxybutanoic acid

C17H30N4O9 (434.2013)


   

Val Thr Glu Ser

(4S)-4-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-4-{[(1S)-1-carboxy-2-hydroxyethyl]carbamoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Val Thr Ser Glu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]pentanedioic acid

C17H30N4O9 (434.2013)


   

Val Thr Thr Asp

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]butanedioic acid

C17H30N4O9 (434.2013)


   

Val Tyr Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Val Tyr Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H30N4O6 (434.2165)


   

Tyr Gly Pro Val

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetyl}pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Tyr Gly Val Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]acetamido}-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Tyr Pro Gly Val

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-methylbutanoic acid

C21H30N4O6 (434.2165)


   

Tyr Pro Val Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]acetic acid

C21H30N4O6 (434.2165)


   

Tyr Val Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]acetyl}pyrrolidine-2-carboxylic acid

C21H30N4O6 (434.2165)


   

Tyr Val Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}acetic acid

C21H30N4O6 (434.2165)


   

Z-Pro-Leu-Gly-NHOH

Z-Pro-Leu-Gly-NHOH

C21H30N4O6 (434.2165)


   

chlorbenzoxamine

chlorbenzoxamine

C27H31ClN2O (434.2125)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

2,3,4-tri-o-benzyl-l-fucopyranose

2,3,4-tri-o-benzyl-l-fucopyranose

C27H30O5 (434.2093)


   

2-Diphenylacetyl-3-(cyclohexyl-hydrazono)indan-1-one

2-Diphenylacetyl-3-(cyclohexyl-hydrazono)indan-1-one

C29H26N2O2 (434.1994)


   

2,6-ditert-butyl-4-[(6-oxobenzo[c][2,1]benzoxaphosphinin-6-yl)methyl]phenol

2,6-ditert-butyl-4-[(6-oxobenzo[c][2,1]benzoxaphosphinin-6-yl)methyl]phenol

C27H31O3P (434.2011)


   

3,4,6-tri-o-benzyl-2-deoxy-d-galactopyranose

3,4,6-tri-o-benzyl-2-deoxy-d-galactopyranose

C27H30O5 (434.2093)


   

Methyl 2,3,5-tri-O-benzyl-beta-D-ribofuranoside

Methyl 2,3,5-tri-O-benzyl-beta-D-ribofuranoside

C27H30O5 (434.2093)


   

1-ethyl-2-[1,2,3,4-tetrahydro-1-(2-hydroxyethyl)-2,2,4-trimethyl-6-quinolyl]benz[cd]indolium chloride

1-ethyl-2-[1,2,3,4-tetrahydro-1-(2-hydroxyethyl)-2,2,4-trimethyl-6-quinolyl]benz[cd]indolium chloride

C27H31ClN2O (434.2125)


   

CTU Guanamine

CTU Guanamine

C17H26N10O4 (434.2138)


   

9,10-BIS(PHENYLETHYNYL)-2-TERT-BUTYLANTHRACENE

9,10-BIS(PHENYLETHYNYL)-2-TERT-BUTYLANTHRACENE

C34H26 (434.2034)


   

Methyl 2,3,4-tri-O-benzyl ribopyranose

Methyl 2,3,4-tri-O-benzyl ribopyranose

C27H30O5 (434.2093)


   

2,4-diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Pyrimidine

2,4-diphenyl-6-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-Pyrimidine

C28H27BN2O2 (434.2165)


   

2,9-Dimethyl-1,10-phenanthroline hemihydrate

2,9-Dimethyl-1,10-phenanthroline hemihydrate

C28H26N4O (434.2107)


   

1-O-methyl-2,3,5-tri-O-benzyl-β-D-ribofuranoside

1-O-methyl-2,3,5-tri-O-benzyl-β-D-ribofuranoside

C27H30O5 (434.2093)


   

3,4,6-tri-o-benzyl-2-deoxy-d-glucopyranose

3,4,6-tri-o-benzyl-2-deoxy-d-glucopyranose

C27H30O5 (434.2093)


   

(3-cyano-1,4-dimethyl-3-phenyl-pentyl)-dimethyl-ammonium citrate

(3-cyano-1,4-dimethyl-3-phenyl-pentyl)-dimethyl-ammonium citrate

C22H30N2O7 (434.2053)


   

Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11beta,16alpha)-

Pregna-1,4-diene-3,20-dione, 9-fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (11beta,16alpha)-

C24H31FO6 (434.2105)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents

   

Fluperolone acetate

Fluperolone acetate

C24H31FO6 (434.2105)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

1-{[1-(2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-2-(3-cyano-phenyl)-ethaneboronic acid

1-{[1-(2-Amino-3-phenyl-propionyl)-pyrrolidine-2-carbonyl]-amino}-2-(3-cyano-phenyl)-ethaneboronic acid

C23H27BN4O4 (434.2125)


   

Flunisolide, >=97\\%

Flunisolide, >=97\\%

C24H31FO6 (434.2105)


   

(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran[2,3:7,8]flavanone

(2S)-6-(gamma,gamma-dimethylallyl)-3,4-dimethoxy-6,6-dimethylpyran[2,3:7,8]flavanone

C27H30O5 (434.2093)


An extended flavonoid that consists of (2S)-flavanone substituted methoxy groups at positions 3 and 4, a prenyl group at position 6 and a gem-dimethylpyran ring fused across positions 7 and 8. Isolated from Lonchocarpus utilis and Lonchocarpus urucu, it acts as a NADH:ubiquinone reductase inhibitor.

   

Asp-Leu-Thr-Ser

Asp-Leu-Thr-Ser

C17H30N4O9 (434.2013)


A tetrapeptide composed of L-aspartic acid, L-leucine, L-threonine and L-serine joined in sequence by peptide linkages.

   

2-Amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile

2-Amino-1-(dimethylamino)-4-(1-naphthalenyl)-5-oxo-7-phenyl-4,6,7,8-tetrahydroquinoline-3-carbonitrile

C28H26N4O (434.2107)


   

Met-Val-Trp

Met-Val-Trp

C21H30N4O4S (434.1988)


   

(6S,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6S,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6S,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6S,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-7-[4-(4-methylpent-1-ynyl)phenyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(1-cyclohexenyl)phenyl]-4-[(3-fluorophenyl)-oxomethyl]-8-(hydroxymethyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C26H27FN2O3 (434.2006)


   

Trp-Met-Val

Trp-Met-Val

C21H30N4O4S (434.1988)


   

Val-Trp-Met

Val-Trp-Met

C21H30N4O4S (434.1988)


   

Met-Trp-Val

Met-Trp-Val

C21H30N4O4S (434.1988)


   

Trp-Val-Met

Trp-Val-Met

C21H30N4O4S (434.1988)


   

Val-Met-Trp

Val-Met-Trp

C21H30N4O4S (434.1988)


   

(2S,4R,10S,14S,16S,18S)-10,14-dimethyl-5-oxospiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2-oxolane]-7-sulonic acid

(2S,4R,10S,14S,16S,18S)-10,14-dimethyl-5-oxospiro[hexacyclo[9.8.0.02,4.05,10.014,19.016,18]nonadecane-15,2-oxolane]-7-sulonic acid

C24H34O5S (434.2127)


   

FLUNISOLIDE

FLUNISOLIDE

C24H31FO6 (434.2105)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents D000893 - Anti-Inflammatory Agents

   

BisMePA(15:2)

BisMePA(4:0_11:2)

C20H35O8P (434.2069)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

MGGA 11:1

MGGA 11:1

C20H34O10 (434.2152)


   

ST 20:0;O5;S

ST 20:0;O5;S

C20H34O8S (434.1974)


   

ST 24:4;O2;S

ST 24:4;O2;S

C24H34O5S (434.2127)


   

Enerisant (hydrochloride)

Enerisant (hydrochloride)

C22H31ClN4O3 (434.2085)


Enerisant (TS-091) hydrochloride is a potent, highly selective, competitive and orally active histamine H3 receptor antagonist/inverse agonist with IC50s of 2.89 nM and 14.5 nM against human and rat histamine H3 receptors, respectively[1].

   

(10e)-11-[5-({[(3s)-3-carboxy-1-hydroxy-3-methylpropylidene]amino}carbonyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

(10e)-11-[5-({[(3s)-3-carboxy-1-hydroxy-3-methylpropylidene]amino}carbonyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

C22H30N2O7 (434.2053)


   

5-hydroxy-7-isopropyl-1,1,4a-trimethyl-6-oxo-3,4-dihydro-2h-phenanthren-3-yl 4-hydroxybenzoate

5-hydroxy-7-isopropyl-1,1,4a-trimethyl-6-oxo-3,4-dihydro-2h-phenanthren-3-yl 4-hydroxybenzoate

C27H30O5 (434.2093)


   

(1r,13z,17s,19s)-9-hydroxy-5,6-dimethoxy-16-oxapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11,13-heptaen-15-one

(1r,13z,17s,19s)-9-hydroxy-5,6-dimethoxy-16-oxapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2,4,6,8(26),9,11,13-heptaen-15-one

C27H30O5 (434.2093)


   

3-hydroxy-3-{[4-(n-hydroxyacetamido)butyl]-c-hydroxycarbonimidoyl}-4-{[3-(n-hydroxyacetamido)propyl]-c-hydroxycarbonimidoyl}butanoic acid

3-hydroxy-3-{[4-(n-hydroxyacetamido)butyl]-c-hydroxycarbonimidoyl}-4-{[3-(n-hydroxyacetamido)propyl]-c-hydroxycarbonimidoyl}butanoic acid

C17H30N4O9 (434.2013)


   

Dexamethasone 21-acetate

Dexamethasone 21-acetate

C24H31FO6 (434.2105)


-

   

Betamethasone 21-acetate

Betamethasone 21-acetate

C24H31FO6 (434.2105)


-

   

[(1s,4as)-5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl]methyl 4-hydroxybenzoate

[(1s,4as)-5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl]methyl 4-hydroxybenzoate

C27H30O5 (434.2093)


   

(5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl)methyl 4-hydroxybenzoate

(5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl)methyl 4-hydroxybenzoate

C27H30O5 (434.2093)


   

2-[(2,6-dimethylhepta-1,5-dien-1-yl)oxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

2-[(2,6-dimethylhepta-1,5-dien-1-yl)oxy]-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxane-3,4,5-triol

C20H34O10 (434.2152)


   

(2r,3r,4s,5s,6r)-2-{[(1z)-2,6-dimethylhepta-1,5-dien-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

(2r,3r,4s,5s,6r)-2-{[(1z)-2,6-dimethylhepta-1,5-dien-1-yl]oxy}-6-({[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}methyl)oxane-3,4,5-triol

C20H34O10 (434.2152)


   

(10z)-11-[5-({[(3s)-3-carboxy-1-hydroxy-3-methylpropylidene]amino}carbonyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

(10z)-11-[5-({[(3s)-3-carboxy-1-hydroxy-3-methylpropylidene]amino}carbonyl)-4-oxo-1h-pyridin-2-yl]undec-10-enoic acid

C22H30N2O7 (434.2053)


   

8-{5-methoxy-6,8,8-trimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl}-2,2-dimethylchromen-5-ol

8-{5-methoxy-6,8,8-trimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl}-2,2-dimethylchromen-5-ol

C27H30O5 (434.2093)


   

(3r,4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-6-oxo-3,4-dihydro-2h-phenanthren-3-yl 4-hydroxybenzoate

(3r,4ar)-5-hydroxy-7-isopropyl-1,1,4a-trimethyl-6-oxo-3,4-dihydro-2h-phenanthren-3-yl 4-hydroxybenzoate

C27H30O5 (434.2093)


   

7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8-dihydroxy-3-[2-(4-hydroxyphenyl)ethyl]isochromen-1-one

7-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6,8-dihydroxy-3-[2-(4-hydroxyphenyl)ethyl]isochromen-1-one

C27H30O5 (434.2093)


   

3,4a,6',7,7',11a-hexamethyl-5,6,6a,11b-tetrahydro-3'h-spiro[cyclohepta[a]naphthalene-4,2'-furo[3,2-c]pyran]-1,4',9-trione

3,4a,6',7,7',11a-hexamethyl-5,6,6a,11b-tetrahydro-3'h-spiro[cyclohepta[a]naphthalene-4,2'-furo[3,2-c]pyran]-1,4',9-trione

C27H30O5 (434.2093)


   

(3r,6r,9r,12r)-3-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

(3r,6r,9r,12r)-3-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

C21H30N4O6 (434.2165)


   

(4s,4ar,6as,11as,11br)-3,4a,6',7,7',11a-hexamethyl-5,6,6a,11b-tetrahydro-3'h-spiro[cyclohepta[a]naphthalene-4,2'-furo[3,2-c]pyran]-1,4',9-trione

(4s,4ar,6as,11as,11br)-3,4a,6',7,7',11a-hexamethyl-5,6,6a,11b-tetrahydro-3'h-spiro[cyclohepta[a]naphthalene-4,2'-furo[3,2-c]pyran]-1,4',9-trione

C27H30O5 (434.2093)


   

3-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

3-(hydroxymethyl)-12-[(4-hydroxyphenyl)methyl]-9-methyl-6-(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

C21H30N4O6 (434.2165)


   

11-(5-{[(3-carboxy-1-hydroxy-3-methylpropylidene)amino]carbonyl}-4-oxo-1h-pyridin-2-yl)undec-10-enoic acid

11-(5-{[(3-carboxy-1-hydroxy-3-methylpropylidene)amino]carbonyl}-4-oxo-1h-pyridin-2-yl)undec-10-enoic acid

C22H30N2O7 (434.2053)


   

[(1r,4ar)-5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl]methyl 4-hydroxybenzoate

[(1r,4ar)-5-hydroxy-7-isopropyl-1,4a-dimethyl-6-oxo-3,4-dihydro-2h-phenanthren-1-yl]methyl 4-hydroxybenzoate

C27H30O5 (434.2093)


   

(5ar,7ar,11as,11br)-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,7a,11b,12-tetrahydro-6h-2,5-dioxatetraphene-1,9-dione

(5ar,7ar,11as,11br)-3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,7a,11b,12-tetrahydro-6h-2,5-dioxatetraphene-1,9-dione

C27H30O5 (434.2093)


   

3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,7a,11b,12-tetrahydro-6h-2,5-dioxatetraphene-1,9-dione

3-(4-methoxyphenyl)-5a,8,8,11a-tetramethyl-7,7a,11b,12-tetrahydro-6h-2,5-dioxatetraphene-1,9-dione

C27H30O5 (434.2093)


   

8-[(3s)-5-methoxy-6,8,8-trimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]-2,2-dimethylchromen-5-ol

8-[(3s)-5-methoxy-6,8,8-trimethyl-2h,3h,4h-pyrano[2,3-f]chromen-3-yl]-2,2-dimethylchromen-5-ol

C27H30O5 (434.2093)


   

7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-3-[2-(4-hydroxyphenyl)ethyl]isochromen-1-one

7-(3,7-dimethylocta-2,6-dien-1-yl)-6,8-dihydroxy-3-[2-(4-hydroxyphenyl)ethyl]isochromen-1-one

C27H30O5 (434.2093)